Biopharmaceutical industry was designated as one of the Korea's ten future growth industries and developing biological new drugs itself is high technology. The biological products arising from their natures request the compliance with the strict manufacturing and quality control standards for commercialization. Considering this, many countries including Korea have developed and complied with separate GMP(Good manufacturing Practice) for biological products in addition to GMP for conventional pharmaceutical products. Today, I am going to briefly explain about Korea's GMP for biological products and related policy agendas in the future. First, I will review the definition, history of GMP and the legal framework of GMP system in Korean pharmaceutical laws and regulations. Next, I will discuss the point when the GMP Should be applied to during the process of the research & development, pre-clinical trials, clinical trials, registration of products and licence approval of biological products and the reason for these applications. The difference of biological and conventional pharmaceutical products in applying the relevant regulations, scope of GMP for biologicals, additional points to consider in GMP for biologicals compared with conventional products and the major inspection check points & the most common inspection findings will be dealt with. Finally, the initiative policies and their progress for GMP for biological products by us, Biologics Management Team will be introduced.
한국생물공학회 [The Korean Society for Biotechnology and Bioengineering]
설립연도
1984
분야
공학>생물공학
소개
이 법인은 생물 공학의 발전과 보급에 이바지하고, 회원 상호 간의 연구 협력과 친목을 도모함을 목적으로 한다
1. 생물공학 분야의 발전을 위한 연구 협력
2. 생물공학의 실용화를 촉진시키기 위한 산학 협동
3. 학술연구 발표회, 강연회, 연수회 등 학술활동의 개최
4. 국,영문 학술지,소식지,학술회의 Proceedings 및 학술도서의 발간
5. 생물공학 발전을 위한 정책 건의
6. 기타 국제 교류 등 본 학회의 목적 달성을 위한 제반 활동